Background: Based on the assumptions that depersonalization symptoms are relevant for test anxiety maintenance, we examined their frequency, psychological predictors, association with anxiety symptoms, and association with test performance. Sampling and Methods: In Study 1, 203 students rated their test anxiety severity and depersonalization in their last oral examination. In Study 2, we assessed test anxiety 1 week before an oral examination, depersonalization, safety behaviors, self-focused attention, and negative appraisals of depersonalization directly after the examination, and post-event processing 1 week later among 67 students. Results: In Study 1, 47.3% reported at least one moderate depersonalization symptom. In Study 2, test anxiety and negative appraisals of depersonalization significantly predicted depersonalization. Depersonalization was linked to a higher intensity of safety behaviors and post-event processing but not to self-focused attention. It was not related to performance. Conclusion: Results are limited by the non-random sampling and the small sample size of Study 2. However, by showing that depersonalization contributes to the processes the maintenance of test anxiety, the findings confirm that depersonalization – normally understood as an adaptive mechanism to cope with stressful events – can become maladaptive.

1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mentaldisorders: DSM-5. Arlington, American Psychiatric Publishing Inc., 2013.
2.
Stein DJ, Koenen KC, Friedman MJ, Hill E, McLaughlin KA, Petukhova M, et al: Dissociation in posttraumatic stress disorder: evidence from the world mental health surveys. Biol Psychiatry 2013; 73: 302–312.
3.
Seguí J, Márquez M, García L, Canet J, Salvador-Carulla L, Oritz M: Depersonalization in panic disorder: a clinical study. Compr Psychiatry 2000; 41: 172–178.
4.
Zanarini MC, Frankenburg FR, Jager-Hyman S, Reich DB, Fitzmaurice G: The course of dissociation for patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. Acta Psychiatr Scand 2008; 118: 291–296.
5.
Aderibigbe YA, Bloch RM, Walker WR: Prevalence of depersonalization and derealization experiences in a rural population. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 63–69.
6.
Hoyer J, Braeuer D, Crawcour S, Klumbies E, Kirschbaum C: Depersonalization/derealization during acute social stress in social phobia. J Anxiety Disord 2013; 27: 178–187.
7.
Lichev V, Wolfradt U: Alexithymia and depersonalization in child sex offenders: the role of emotion regulation. Int J of Forensic Mental Health 2016;15:274–282.
8.
Wolfradt U, Engelmann S: Depersonalization, fantasies, and coping behavior in clinical context. J Clin Psychol 2003; 59: 1117–1124.
9.
Sierra M, Senior C, Dalton J, McDonough M, Bond A, Phillips ML, O’Dwyer AM, David AS: Autonomic response in depersonalization disorder. Arch Gen Psychiatry 2002; 59: 833–888.
10.
Sierra M, Berrios GE: Depersonalization: neurobiological perspectives. Biol Psychiatry 1998; 44: 898–908.
11.
Ludwig AM: The psychobiological function of dissociation. Am J of Clin Hypn 1983; 26: 93–99.
12.
Scaer RC: The neurophysiology of dissociation and chronic disease. Appl Psychophysiol Biofeedback 2001; 26: 73–91.
13.
Jacobson E: Depersonalization. J Am Psychoanal Assoc 1959; 7: 581–610.
14.
Oberndorf CP: The role of anxiety in ­depersonalization. Int J Psychoanal 1950; 31: 1–5.
15.
Beilock SL, Carr TH: On the fragility of skilled performance: what governs choking under pressure? J Exp Psychol Gen 2001; 130: 701–725.
16.
Zeidner M: Test Anxiety: The State of the Art. New York, Plenum Press, 1998.
17.
Beidel DC, Turner SM: Comorbidity of test anxiety and other anxiety disorders in children. J Abnorm Child Psychol 1988; 16: 275–287.
18.
Brown LA, Forman EM, Herbert JD, Hoffman KL, Yuen EK, Goetter EM: A randomized controlled trial of acceptance-based behavior therapy and cognitive therapy for test anxiety: a pilot study. Behav Modif 2011; 35: 31–53.
19.
McDonald A: The prevalence and effects of test anxiety in school children. Educ Psychol 2001; 21: 89–101.
20.
Eum K, Rice KG: Test anxiety, perfectionism, goal orientation, and academic performance. Anxiety Stress Coping 2011; 24: 167–178.
21.
Talin N, Sansgiry SS: Determinants of academic performance of university students. Pak J Psychol Res 2012; 27: 265–278.
22.
Bögels SM, Alden L, Beidel DC, Clark LA, Pine DS, Stein MB, Voncken M: Social ­anxiety disorder: questions and answers for the DSM-V. Depress Anxiety 2010; 27: 168–189.
23.
Clark DM, Wells A: A cognitive model of social phobia; in RG Heimberg, M Liebowitz, DA Hope, F Schneier (eds): Social Phobia: Diagnosis, Assessment, and Treatment. New York, Guilford, 1995, pp 69–93.
24.
Hofmann SG: Cognitive factors that maintain social anxiety disorder: a comprehensive model and its treatment implication. Cogn Behav Ther 2007; 36: 193–209.
25.
Rapee RM, Heimberg RG: A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther 1997; 35: 741–756.
26.
Bögels SM, Mansell W: Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention. Clin Psychol Rev 2004; 24: 827–856.
27.
Carver CS, Peterson LM, Follansbee DJ, Scheier MF: Effects of self-directed attention on performance and persistence among persons high and low in test anxiety. Cogn Ther Res 1983; 7: 333–354.
28.
Feiler AR, Powell DM: The role of self-focused attention and negative self-thought in interview anxiety: a test of two interventions. Int J Sel Assess 2016; 24: 132–149.
29.
McManus F, Sacadura C, Clark DM: Why social anxiety persists: an experimental investigation of the role of safety behaviours as a maintaining factor. J Behav Ther Exp Psychiatry 2008; 39: 147–161.
30.
Wells A, Clark DM, Salkovskis P, Ludgate J, Hackmann A, Gelder M: Social phobia: the role of in-situation safety behaviors in maintaining anxiety and negative beliefs. Behavior Therapy 1995; 26: 153–161.
31.
Brozovich F, Heimberg RG: An analysis of post-event processing in social anxiety disorder. Clin Psychol Rev 2008; 28: 891–903.
32.
Helbig-Lang S, von Auer M, Neubauer K, Murray E, Gerlach A: Post-event processing in social anxiety disorder after real-life social situations – an ambulatory assessment study. Behavior Research Therapy 2016; 84: 27–34.
33.
Hunter ECM, Philipps ML, Chalder T, Sierra M, David AS: Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behav Res Ther 2003; 41: 1451–1467.
34.
Hunter, ECM, Salkovskis PM, David AS: Attributions, appraisals and attention for symptoms in depersonalisation disorder. Behav Res Ther 2014; 53: 20–29.
35.
Hunter, ECM, Sierra M, David AS: The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 9–18.
36.
Guralnik O, Schmeidler J, Simeon D: Feeling unreal: cognitive processes in depersonalization. Am J Psychiatry 2000; 157: 103–109.
37.
Özdemir O, Özdemir G, Boysan M, Yilmaz E: The relationships between dissociation, attention, and memory dysfunction. Noro Psikiyatr 2015; 52: 36–41.
38.
Pérez-Fabello MJ, Campos A: Dissociative experiences, creative imagination, and artistic production in students of fine arts. Think Skills Creat 2011; 6: 44–48.
39.
Sierra M, Berrios GE: The Cambridge depersonalization scale: a new instrument for the measurement of depersonalization. Psychiatry Res 2000; 93: 153–164.
40.
Michal M, Sann U, Niebecker M, Lazanowsky C, Kernhof K, Aurich S, Overbeck G, Sierra M, Berrios GE: Die erfassung des depersonalisations-derealisations-syndroms mit der deut. Version der Cambridge depersonalisation scale (CDS). Psychother Psychosom Med Psychol 2004; 54: 367–374.
41.
Hodapp V, Rohrmann S, Ringeisen T: Prüfungsangstfragebogen (PAF). Göttingen, Hogrefe, 2011.
42.
Leising D: The consistency bias in judgements of one’s interpersonal behavior. Two possible sources. J of Individ Differ 2011; 32: 137–143.
43.
Sadler P, Woody E: Is who you are who you’re talking to? Interpersonal style and complementarity in mixed-sex interactions. J Pers Soc Psychol 2003; 84: 80–96.
44.
Stangier U, Heidenreich T, Peitz M: Soziale Phobien. Ein kognitiv-verhaltenstherapeutisches Behandlungsmanual. Weinheim, Beltz, 2003.
45.
Woody SR, Chambless DL, Glass CR: Self-focused attention in the treatment of social phobia. Behav Res Ther 1996; 35: 117–129.
46.
Rachman S, Grueter-Andrew J, Shafran R: Post-event processing is social anxiety. Behav Res Ther 2000; 38: 741–756.
47.
Fehm L, Hoyer J, Schneider G, Lindemann C, Klusmann U: Assessing post-event processing after social situations: A measure based on the cognitive model for social phobia. Anxiety Stress Coping 2008; 21: 129–142.
48.
Podsakoff PM, MacKenzie SB, Lee JY, Podsakoff NP: Common method biases in behavioral research: A critical review of the literature and recommended remedies. J Appl Psycholo 2003; 88: 879–903.
49.
Freyd JJ, Martorello SR, Alvardo JS, Hayes AE, Christman JC: Cognitive enviroments and dissociative tendencies: performance on the standard Stroop task for high versus low dissociators. Appl Cogn Psychol 1998; 12: 91–103.
50.
DePrince AP, Freyd JJ: Dissociative tendencies, attention, and memory. Psychol Sci 1999; 10: 449–452.
51.
Schmeichel BJ, Baumeister RF: Effortful attention control; in Bruya B (ed): Effortless Attention: A New Perspective in the Cognitive Science of Attention and Action. Cambridge, MIT Press, 2010, pp 29–49.
52.
Eysenck MW, Derakshan N, Santos R, Calvo MG: Anxiety and cognitive performance: attentional control theory. Emotions 2007; 7: 336–353.
53.
Klosterkötter J: Indicated prevention of schizophrenia. Dtsch Arztebl Int 2008; 105: 532–539.
54.
Simon AE, Umbricht D, Lang UE, Borgwardt S: Declining transition rates to psychosis: The role of diagnostic spectra and symptom overlap in individuals with attenuated psychosis syndrome. Schizophr Res 2014; 159: 292–298.
55.
Schweden TLK, Pittig A, Braeuer D, Klumbies E, Kirschbaum C, Hoyer J: Reduction of depersonalization during social stress through cognitive therapy for social anxiety disorder: a randomized controlled trial. J Anxiety Disord 2016; 43: 99–105.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.